|
Name |
1,1-Dimethoxynonane
|
Molecular Formula | C11H24O2 | |
IUPAC Name* |
1,1-dimethoxynonane
|
|
SMILES |
CCCCCCCCC(OC)OC
|
|
InChI |
InChI=1S/C11H24O2/c1-4-5-6-7-8-9-10-11(12-2)13-3/h11H,4-10H2,1-3H3
|
|
InChIKey |
LYLVOCPDQAOQKL-UHFFFAOYSA-N
|
|
Synonyms |
1,1-Dimethoxynonane; 18824-63-0; Nonanal dimethyl acetal; Nonane, 1,1-dimethoxy-; 1,1-dimethoxy-nonane; n-Nonanal dimethyl acetal; Pelargonaldehyde Dimethyl Acetal; R293HT233N; UNII-R293HT233N; EINECS 242-603-3; 1,1-Dimethoxynonane #; AI3-36124; 1,1-Dimethoxynonane, 9CI; SCHEMBL873446; Nonyl Aldehyde Dimethyl Acetal; NONANAL, DIMETHYL ACETAL; DTXSID8066424; FEMA NO. 4367; CHEBI:183015; ZINC2168243; MFCD00036646; AKOS006275074; NONANAL DIMETHYL ACETAL [FHFI]; AS-57744; PELARGONIC ALDEHYDE DIMETHYL ACETAL; CS-0152271; FT-0690784; N0915; D97662; Q27287701
|
|
CAS | 18824-63-0 | |
PubChem CID | 87813 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 188.31 | ALogp: | 4.1 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 9 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 18.5 | Aromatic Rings: | 0 |
Heavy Atoms: | 13 | QED Weighted: | 0.4 |
Caco-2 Permeability: | -4.306 | MDCK Permeability: | 0.00002250 |
Pgp-inhibitor: | 0.035 | Pgp-substrate: | 0.076 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.94 |
30% Bioavailability (F30%): | 0.83 |
Blood-Brain-Barrier Penetration (BBB): | 0.621 | Plasma Protein Binding (PPB): | 91.19% |
Volume Distribution (VD): | 1.03 | Fu: | 7.17% |
CYP1A2-inhibitor: | 0.082 | CYP1A2-substrate: | 0.863 |
CYP2C19-inhibitor: | 0.163 | CYP2C19-substrate: | 0.879 |
CYP2C9-inhibitor: | 0.216 | CYP2C9-substrate: | 0.126 |
CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.123 |
CYP3A4-inhibitor: | 0.034 | CYP3A4-substrate: | 0.201 |
Clearance (CL): | 7.756 | Half-life (T1/2): | 0.261 |
hERG Blockers: | 0.046 | Human Hepatotoxicity (H-HT): | 0.023 |
Drug-inuced Liver Injury (DILI): | 0.029 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.023 | Maximum Recommended Daily Dose: | 0.022 |
Skin Sensitization: | 0.882 | Carcinogencity: | 0.104 |
Eye Corrosion: | 0.944 | Eye Irritation: | 0.987 |
Respiratory Toxicity: | 0.055 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000558 | 0.568 | D05ATI | 0.339 | ||||
ENC000459 | 0.537 | D0Z5SM | 0.304 | ||||
ENC000797 | 0.535 | D0G2KD | 0.289 | ||||
ENC002416 | 0.532 | D0AY9Q | 0.279 | ||||
ENC000490 | 0.532 | D00FGR | 0.276 | ||||
ENC001155 | 0.532 | D0MM8N | 0.275 | ||||
ENC000261 | 0.525 | D05QNO | 0.273 | ||||
ENC001156 | 0.510 | D02MLW | 0.271 | ||||
ENC001237 | 0.500 | D0E4WR | 0.268 | ||||
ENC000850 | 0.500 | D03ZJE | 0.267 |